about
Role of NADPH oxidase in formation and function of multinucleated giant cellsAldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Vascular damage in giant cell arteritis.IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritisSerpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritisSelective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approachReactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillariesTrapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cellsGiant cell arteritis: the importance of immediate and appropriate diagnosis and treatment for better prognosis.Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupusActivation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritisOccurrence of giant cell arteritis...suddenly.Toll-like receptors 4 and 5 induce distinct types of vasculitis.A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.
P2860
Q24633426-B8F4D560-D711-48C7-9881-5844CC328677Q33848421-3827FD29-DC00-4F8C-A08B-DAAE49D620E9Q34377832-5CF631A8-97F7-48E6-BBF2-7570E15B313FQ34743236-0736BF09-6E0A-4A34-BE26-6CC8C85C9935Q34847819-C4D569E9-25E4-4784-9BD3-7A56690EEFFBQ35058267-86542AFE-90FE-4471-BDDF-D81C7F957AF2Q35553184-C6BBA2D0-734F-4F44-ABB1-CF1CB159D952Q35557980-A4A18F01-64AF-4A2B-91D2-6F16FA65C30CQ35747507-A6B92E0E-3C95-43C7-B87C-FD2550CC7DDCQ35747868-9AA4DBFF-2528-4136-A14F-41AE70D7A9D6Q35787897-0FD46F34-322D-4D6D-8D92-64C6A00B458AQ36085232-C7B63C5E-8BA6-4E0F-97B5-BB8A30F4C3E6Q36101077-18BB16C0-2D7E-40AA-8B5D-B36141D1D0FDQ36399030-F8F624CC-D80F-472D-90DE-CC28E8B3380AQ36481836-799B2B70-1718-4382-8BB7-B062FD919565Q37317964-1428FB28-FBFE-4492-B071-8681D665C471Q40353901-26AD9F1C-5205-4104-BA23-C50C3527AB5DQ40353912-C8731A3C-05C0-4763-8E9D-114D286AD1F6Q42380775-DA0B73C5-1492-4799-AB74-24787978D3BAQ42689593-DB5AEF8A-ED1C-4081-8BD8-DE40E5D1C16EQ48099660-CB5BC823-FFBC-4F3C-AAA6-D905B86D6E87
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Giant cell vasculitis is a T cell-dependent disease
@ast
Giant cell vasculitis is a T cell-dependent disease
@en
type
label
Giant cell vasculitis is a T cell-dependent disease
@ast
Giant cell vasculitis is a T cell-dependent disease
@en
prefLabel
Giant cell vasculitis is a T cell-dependent disease
@ast
Giant cell vasculitis is a T cell-dependent disease
@en
P2093
P2860
P356
P1433
P1476
Giant cell vasculitis is a T cell-dependent disease
@en
P2093
B R Younge
C M Weyand
J J Goronzy
V M Martinez-Taboada
P2860
P2888
P304
P356
10.1007/BF03401699
P407
P577
1997-08-01T00:00:00Z